MSV
WST icon

MN Services Vermogensbeheer’s West Pharmaceutical WST Stock Holding History

MN Services Vermogensbeheer’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.48M Sell
20,824
-7,700
-27% -$2.35M 0.06% 286
2026
Q1 		$7.15M Hold
28,524
– – 0.05% 309
2025
Q4 		$7.85M Buy
28,524
+1,824
+7% +$499K 0.05% 307
2025
Q3 		$7M Hold
26,700
– – 0.05% 334
2025
Q2 		$5.84M Hold
26,700
– – 0.04% 367
2025
Q1 		$5.98M Sell
26,700
-2,100
-7% -$579K 0.05% 334
2024
Q4 		$9.43M Buy
28,800
+500
+2% +$157K 0.06% 271
2024
Q3 		$8.49M Sell
28,300
-700
-2% -$214K 0.06% 282
2024
Q2 		$9.55M Sell
29,000
-900
-3% -$318K 0.07% 258
2024
Q1 		$11.8M Sell
29,900
-5,100
-15% -$1.89M 0.09% 229
2023
Q4 		$12.3M Sell
35,000
-1,300
-4% -$460K 0.11% 212
2023
Q3 		$13.6M Buy
36,300
+900
+3% +$348K 0.13% 198
2023
Q2 		$13.5M Sell
35,400
-1,200
-3% -$429K 0.13% 209
2023
Q1 		$12.7M Buy
36,600
+1,200
+3% +$351K 0.13% 205
2022
Q4 		$8.33M Sell
35,400
-5,500
-13% -$1.3M 0.09% 257
2022
Q3 		$10.1M Sell
40,900
-2,700
-6% -$823K 0.11% 235
2022
Q2 		$13.2M Sell
43,600
-9,200
-17% -$2.99M 0.12% 206
2022
Q1 		$21.7M Sell
52,800
-3,700
-7% -$1.45M 0.14% 170
2021
Q4 		$26.5M Buy
56,500
+1,300
+2% +$560K 0.16% 167
2021
Q3 		$23.4M Buy
55,200
+800
+1% +$337K 0.14% 180
2021
Q2 		$16.5M Buy
+54,400
New +$18M 0.13% 194
2020
Q4 		$18.3M Buy
64,700
+1,000
+2% +$281K 0.13% 186
2020
Q3 		$17.5M Buy
63,700
+800
+1% +$212K 0.14% 175
2020
Q2 		$14.3M Buy
+62,900
New +$12.4M 0.12% 189

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

MN Services Vermogensbeheer's WST Position: Q2 2026 in Review

MN Services Vermogensbeheer reduced its West Pharmaceutical (WST) stake by 27% in Q2 2026, selling an estimated $2.35M and leaving 20,824 shares worth $7.48M. The position accounts for 0.06% of the portfolio, ranked #286.

MN Services Vermogensbeheer first reported a position in WST in Q2 2020 and has held it in 24 quarters since. The position peaked at $26.5M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • MN Services Vermogensbeheer held 20,824 shares of West Pharmaceutical worth $7.48M as of Q2 2026.
  • MN Services Vermogensbeheer sold 7,700 West Pharmaceutical shares in Q2 2026, an estimated $2.35M.
  • West Pharmaceutical made up 0.06% of MN Services Vermogensbeheer's portfolio in Q2 2026, its #286 holding.
  • MN Services Vermogensbeheer first reported a position in West Pharmaceutical in Q2 2020 and has held it in 24 quarters since.
  • MN Services Vermogensbeheer's West Pharmaceutical position peaked at $26.5M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q2 2026, filed 31 Jul 2026.